Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bavisant dihydrochloride hydrate'

Search results for: 'bavisant dihydrochloride hydrate'

Items 181-190 of 274

Page
per page
  1. DiscoveryProbe™ Human Endogenous Metabolite Compound Library
    L1051 DiscoveryProbe™ Human Endogenous Metabolite Compound Library
    Summary: A collection of 548 Human Endogenous Metabolite Compound supplied as lyophilized powder or pre-dissolved DMSO solutions
  2. DiscoveryProbe™ FDA-approved Drug Library
    L1021 DiscoveryProbe™ FDA-approved Drug Library
    Summary: 2320 approved drugs and API from pharmacopoeia
  3. Amodiaquine hydrochloride
    C7157 Amodiaquine hydrochloride
      ≥55.5 mg/mL
  4. B-HT 920
    A3239 B-HT 920
    Summary: D2 receptor agonist
      Soluble in DMSO
  5. NNC 55-0396
    A3662 NNC 55-0396
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: T-type calcium channel blocker
      Soluble to 25 mM in sterile water
  6. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  7. Cefotiam hydrochloride
    C6490 Cefotiam hydrochloride
      insoluble in EtOH; ≥32.45 mg/mL
  8. Sitagliptin phosphate monohydrate
    A4036 Sitagliptin phosphate monohydrate
     5 Citation
    Target: DPP-4
    Summary: Potent DPP-4 inhibitor
      ≥23.8 mg/mL
  9. Cyclophosphamide monohydrate
    A4232 Cyclophosphamide monohydrate
    Summary: alkylating, cytotoxic agent,antitumor activity
      ≥13.95 mg/mL
  10. Vardenafil HCl Trihydrate
    A4323 Vardenafil HCl Trihydrate
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor, potent and selective
      ≥13.3 mg/mL

Items 181-190 of 274

Page
per page